GigaSpaces Raises $20 Million to Seize Momentum in Hyper-Growth Cloud Market
20.1.2016 13:03 | Business Wire
GigaSpaces Technologies, provider of pure-play cloud orchestration and data scalability platforms, has raised over $20 million in a new round. The investment was led by Claridge Israel (CI), a partnership between Claridge Inc. /the Stephen R. Bronfman Family Office and la Caisse de dépôt et placement du Québec (CDPQ) focused on solid, growth companies that possess a technological advantage, and with the participation of existing investors including BRM, FTV and Intel Capital.
Funding will accelerate global awareness and adoption of GigaSpaces’ cloud application orchestration and data scalability solutions, drive continued product innovation, and expand its sales organization worldwide in the area of hybrid cloud, NFV and real-time analytics.
The investment follows GigaSpaces’ best year to date in revenue. Hundreds of tier-1 enterprises and carriers currently run GigaSpaces flagship products, Cloudify and XAP, in production deployments across multiple industries to enhance IT efficiency and performance. In 2015 alone, the company has reached milestone accomplishments, including
- Achieved record annual revenue
- Tripled product adoption
- Closed several record multi-million dollar deals from tier-one enterprises for both Cloudify and XAP
- Implemented Cloudify orchestration at more than 20 Telco providers for NFV initiatives.
“CI’s investment is a testament to the fact that GigaSpaces has developed a portfolio of technologies, products and customer pipeline that comprise a growth engine,” said Zeev Bikowsky, CEO at GigaSpaces. “This speaks to the importance of giving enterprises and carriers a pure-play orchestration option for management and automation across VMware, OpenStack and public cloud environments. Similarly, we solve the problem of collecting and analyzing vast amounts of information about application behavior in real-time."
“We are excited about GigaSpaces, and its profile very much fits our investment strategy - a solid company that holds a technological advantage and that can pursue substantial growth opportunities in more than one area,” said Oded Tal, CI's Managing Director. “GigaSpaces is now well positioned in two areas with high growth potential – cloud and real-time analytics. We hope that this investment will allow the company to leverage its capabilities and further scale its business across the board.”
GigaSpaces Technologies provides pure-play cloud orchestration and data scalability platforms through two main product lines, Cloudify and XAP. Hundreds of Tier-1 organizations worldwide are leveraging GigaSpaces’ technology to enhance IT efficiency and performance, from top financial and insurance firms, Telco carriers, e-Commerce companies, transportation firms and healthcare organizations. GigaSpaces maintains offices in the US, Europe and Asia Pacific. More at www.gigaspaces.com
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 06:00 | Pressemelding
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and
Permasteelisa Group to Join Grandland21.8.2017 04:11 | Pressemelding
Worldwide leading contractor in engineering, project management, manufacturing and installation of architectural envelopes and interior systems, Permasteelisa Group, will join forces with Grandland Group – a fast growing, Shenzhen-based specialist in design and construction of architectural decoration. The strategic alliance will create the biggest, most comprehensive curtain wall player in the world, with exceptional potential for further growth for both companies. Permasteelisa will remain fully committed to build avant-garde architectures and top end, high-quality projects which have become its trademark. The news comes today after LIXIL Group Corporation (LIXIL Group) (TOKYO: 5938) – a global leader in the housing and building industry – announced that it has decided to sell 100% of shares of Permasteelisa S.p.A., held by its major subsidiary LIXIL Corporation, to Grandland Holding
LIXIL to Sell Permasteelisa to Grandland21.8.2017 03:42 | Pressemelding
LIXIL Group Corporation (LIXIL Group) (TOKYO:5938), a global leader in the housing and building industry, today announced that it has decided to sell 100% of the shares of Permasteelisa S.p.A (Permasteelisa) held by its major subsidiary LIXIL Corporation to Grandland Holdings Group Limited (Grandland), a leading Chinese architectural design and construction company. The transaction is subject to customary closing conditions and regulatory approvals, including in China, the United States and Russia. Under the terms of the agreement, the base sale price for Permasteelisa is EURO 467 million. As a result of this transaction and the deconsolidation of Permasteelisa from LIXIL Group, LIXIL Group’s revenue for the full fiscal year ending March 2018 is expected to decrease by approximately 170.0 billion yen from the amount announced on May 8, 2017 (by approximately 9.2% of the previously fore
Samsung Bioepis and Takeda Sign Strategic Collaboration Agreement to Co-Develop Multiple Novel Biologic Therapies20.8.2017 23:30 | Pressemelding
Samsung Bioepis Co., Ltd. announced today that it has entered into a strategic collaboration agreement with Takeda Pharmaceutical Company Limited (TSE: 4502) to jointly fund and co-develop multiple novel biologic therapies in unmet disease areas. The two companies will immediately begin working on the program’s first therapeutic candidate, TAK-671, which is intended to treat severe acute pancreatitis. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170820005028/en/ Christopher Hansung Ko, President & CEO of Samsung Bioepis. (Photo: Business Wire) “Takeda’s extensive knowledge and expertise in drug development makes the company an ideal partner for us as we open a new chapter at Samsung Bioepis,” said Christopher Hansung Ko, President and CEO, Samsung Bioepis. “Five years ago, we entered
The Valence Group Issues Fairness Opinion to SK Capital in Connection with Archroma18.8.2017 13:30 | Pressemelding
The Valence Group has provided a fairness opinion to SK Capital Partners, LP in connection with its recapitalization of Archroma, including investments made by various affiliates of SK Capital. Terms of the transaction were not disclosed. About SK Capital SK Capital is a private investment firm focused on the specialty materials, chemicals and pharmaceutical sectors. The firm builds strong and growing businesses that generate substantial long-term value for its investors. SK Capital utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing companies with improved strategic positioning, growth, profitability and risk profiles. The firm currently has approximately $1.9 billion of assets under management and its portfolio companies generate revenues of over $5.0 billion annually and employ approximat
Biker Summer 2017 campaign: What’s happening during Biker Summer 2017? Moto-tyres.co.uk is giving away exciting prizes!18.8.2017 09:22 | Pressemelding
Whether it’s a short weekend break or a long-distance tour – once again this year Moto-tyres.co.uk is asking bikers from 10 countries about their dream destinations and longest journeys as part of its “Biker Summer 2017” campaign. To ensure than nothing gets in the way of your next tour, the two-wheeler tyre store from Delticom, Europe’s leading online tyre dealer, is entering anyone who completes the survey before 30 September 2017 into a prize draw to win some great biking accessories. Simply answer three short questions about your plans for bike tours this year (don’t forget to provide your name and email address), and with a bit of luck, you might win one of these great prizes. Up for grabs are a GARMIN motorbike GPS system, a GoPro camera with helmet bracket and five 200-Pound vouchers for new motorbike tyres from the online store – thanks to the product range at Moto-tyres.co.uk, eve
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom